Analysis of Neurofibromatosis 1 (NF1) Lesions by Body Segment

American Journal of Medical Genetics

Volumn 125 A, Issue 2, 2004, Pages 157-161

  Palmer, Chana ^a,b   Szudek, Jacek ^a,c   Joe, Harry ^a   Riccardi, Vincent M ^d   Friedman, J M ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b STANFORD UNIVERSITY   (United States)

^c DALHOUSIE UNIVERSITY   (Canada)

^d American Medical Consumers   (United States)

Author keywords

Caf au lait spots; Familial correlation; Neurofibromas; Neurofibromatosis 1

Indexed keywords

ARTICLE; CAFE AU LAIT SPOT; CORRELATION FUNCTION; FAMILY STUDY; HUMAN; MAJOR CLINICAL STUDY; NEUROFIBROMA; NEUROFIBROMATOSIS; PRIORITY JOURNAL; TISSUE DISTRIBUTION;

EID: 1442308629     PISSN: 15524825     EISSN: None     Source Type: Journal    
DOI: 10.1002/ajmg.a.20354     Document Type: Article

References (26)

1. Abeliovich D, Gelman-Kohan Z, Silverstein S, Lerer I, Chemke J, Merin S, Zlotogora J. 1995. Familial cafe au lait spots: A variant of neurofibromatosis type 1. J Med Genet 32:985-986.
2. Burger P, Scheithauer B. 1994. Tumors of the central nervous system. In: Atlas of tumor pathology. Fascicle 10. Washington, DC: Armed Forces Institute of Pathology.
3. Cichowski K, Shih TS, Schmitt E, Santiago S, Reilly K, McLaughlin ME, Bronson RT, Jacks T. 1999. Mouse models of tumor development in neurofibromatosis type 1. Science 286:2172-2176.
4. DeBella K, Szudek J, Friedman JM. 2000. Use of the national institutes of health criteria for diagnosis of neurofibromatosis 1 in children. Pediatrics 105:608-614.
5. Donner A, Wells G, Eliasziw M. 1989. On two approximations to the F-distribution: Application to testing for intraclass correlation in family studies. Canadian J Statistics 17:209-215.
6. Easton D, Ponder M, Huson S, Ponder B. 1993. An analysis of variation in expression of neurofibromatosis (NF) type I (NFI): Evidence for modifying genes. Am J Hum Genet 53:305-313.
7. Feigenbaum L, Fujita K, Collins FS, Jay G. 1996. Repression of the NF1 gene by Tax may expain the development of neurofibromas in human T-lymphotropic virus type 1 transgenic mice. J Virol 70:3280-3285.
8. Fitzpatrick TB. 1981. Melanin synthesis pathways in the pathogenesis of neurofibromatosis. Adv Neurol 29:209-211.
9. Friedman JM, Riccardi VM. 1999. Clinical and epidemiological features. In: Friedman JM, Gutmann DH, MacCollin M, Riccardi VM, editors. Clinical and epidemiological features. Baltimore: Johns Hopkins University Press. pp 29-86.
10. Giorno R, Lieber J, Claman HN. 1989. Ultrastructural evidence for mast cell activation in a case of neurofibromatosis. Neurofibromatosis 2:35-41.
11. Gutmann D, Aylsworth A, Carey J, Korf B, Marks J, Pyeritz R, Rubenstein A, Viskochil D. 1997. The diagnostic evaluation and multidisciplinary management of neurofibromatosis 1 and neurofibromatosis 2. JAMA 278:51-57.
12. Harkin J, Reed R. 1969. Tumors of the peripheral nervous system. Tumors of the peripheral nervous system. Washington, DC: Armed Forces Institute of Pathology. pp 67-100.
13. Korf BR. 1999. Plexiform neurofibromas. Am J Med Genet 89:31-37.
14. McManus WF, Pruitt BA Jr. 1996. Thermal injuries. In: Feliciano DV, Moore EE, Mattox KL, editors. Trauma, 3rd ed. Stamford, Connecticut: Appleton & Lange. pp 937-949.
15. Miller R. 1974. The jackknife-a review. Biometrika 61:1-15.
16. National Institutes of Health Consensus Development Conference. 1988. Neurofibromatosis: Conference statement. Arch Neurol 45:575-578.
17. Riccardi V. 1990. The potential role of trauma and mast cells in the pathogenesis of neurofibromas. In: Ishibashi Y, Hori Y, editors. The potential role of trauma and mast cells in the pathogenesis of neurofibromas. Elsevier, Amsterdam. pp 167-190.
18. Riccardi VM. 1992. Neurofibromatosis: Phenotype, natural history, and pathogenesis. Baltimore: The Johns Hopkins University Press.
19. Spjotvoll E. 1967. Optimum invariant tests in unbalanced variance component models. Ann Math Statist 38:422-428.
20. SPSS. 1998. SPSS for Windows. Ver. 9.0.0.
21. Szudek J, Birch P, Riccardi VM, Evans DG, Friedman JM. 2000a. Associations of clinical features in neurofibromatosis 1 (NF1). Genet Epidemiol 19:429-439.
22. Szudek J, Joe H, Friedman JM. 2000b. Familial aggregation of neurofibromatosis 1 (NF1) clinical features. Am J Hum Genet 67:211.
23. Szudek J, Joe H, Friedman JM. 2002. Analysis of intra-familial phenotypic correlation in neurofibromatosis 1 (NF1). Genet Epidemiol 23:150-164.
24. Szudek J, Evans D, Friedman JM. 2003. Logistic regresssive models of neurofibromatosis 1 (NF1) clinical features. Hum Genet 112:289-297.
25. Vogel KS, Klesse LJ, Velasco-Miguel S, Meyers K, Rushing EJ, Parada LF. 1999. Mouse tumor model for neurofibromatosis type 1. Science 286:2176-2179.
26. Woodruff JM. 1999. Pathology of tumors of the peripheral nerve sheath in type 1 neurofibromatosis. Am J Med Genet 89:23-30.